Ardelyx, Inc. Gains 32.24%
Tue, Nov 30, 2021 at 05:30 PM
Ardelyx, Inc. (ARDX:NASDAQ) soared at $1.14, representing a gain of 32.2%. On Mon, Nov 29, 2021, ARDX:NASDAQ touched a New 2-Week Low of $0.86. The stock appeared on our News Catalysts scanner on Fri, Nov 12, 2021 at 08:06 AM in the 'EARNINGS' category. From Mon, Nov 15, 2021, the stock recorded 22.22% Up Days and 10.00% Green Days
About Ardelyx, Inc. (ARDX:NASDAQ)
Ardelyx Inc is a clinical stage biopharmaceutical company. It engages in the discovery, development and commercialization of non-systemic, molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal and metabolic diseases.
Top 10 Gainers:
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 128.64%
- iFresh Inc. (IFMK:NASDAQ), 50%
- VOSO (VOSO:NASDAQ), 43.95%
- MEI Pharma, Inc. (MEIP:NASDAQ), 37.55%
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 32.5%
- Ardelyx, Inc. (ARDX:NASDAQ), 32.24%
- ImmunoGen, Inc. (IMGN:NASDAQ), 29.89%
- Gritstone Oncology, Inc. (GRTS:NASDAQ), 25.71%
- CLNN (CLNN:NASDAQ), 22.37%
- GBS (GBS:NASDAQ), 22.22%